Literature DB >> 28740705

A closer look at the safety and effectiveness of modern PORT in stage III-N2 non-small cell lung cancer.

Charlotte Billiet1,2, Dirk De Ruysscher1,3.   

Abstract

Entities:  

Year:  2017        PMID： 28740705      PMCID： PMC5506152          DOI： 10.21037/jtd.2017.05.66

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

1.  Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection.

Authors:  Charlotte Billiet; Stéphanie Peeters; Herbert Decaluwé; Johan Vansteenkiste; Christophe Dooms; Christophe M Deroose; Marc Hendrikx; Paul De Leyn; Paul Bulens; Rezaul Karim; Cécile Le Péchoux; Jeroen Mebis; Dirk De Ruysscher
Journal:  J Thorac Oncol       Date:  2016-07-05       Impact factor: 15.609

2.  Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement.

Authors:  Cecile Le Péchoux; Ariane Dunant; Jean-Pierre Pignon; Dirk De Ruysscher; Françoise Mornex; Suresh Senan; Francesc Casas; Allan Price; Bernard Milleron
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

3.  Postoperative radiotherapy and lung cancer in stage III: helpful or harmful.

Authors:  Francesco Fiorica
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 4.  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Authors:  Anne Aupérin; Cecile Le Péchoux; Estelle Rolland; Walter J Curran; Kiyoyuki Furuse; Pierre Fournel; Jose Belderbos; Gerald Clamon; Hakki Cuneyt Ulutin; Rebecca Paulus; Takeharu Yamanaka; Marie-Cecile Bozonnat; Apollonia Uitterhoeve; Xiaofei Wang; Lesley Stewart; Rodrigo Arriagada; Sarah Burdett; Jean-Pierre Pignon
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

5.  Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.

Authors:  Jan P van Meerbeeck; Gijs W P M Kramer; Paul E Y Van Schil; Catherine Legrand; Egbert F Smit; Franz Schramel; Vivianne C Tjan-Heijnen; Bonne Biesma; Channa Debruyne; Nico van Zandwijk; Ted A W Splinter; Giuseppe Giaccone
Journal:  J Natl Cancer Inst       Date:  2007-03-21       Impact factor: 13.506

Review 6.  Postoperative radiotherapy for non-small cell lung cancer.

Authors:  Sarah Burdett; Larysa Rydzewska; Jayne Tierney; David Fisher; Mahesh Kb Parmar; Rodrigo Arriagada; Jean Pierre Pignon; Cecile Le Pechoux
Journal:  Cochrane Database Syst Rev       Date:  2016-10-11

7.  Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.

Authors:  Daniel C Betticher; Shu-Fang Hsu Schmitz; Martin Tötsch; Eva Hansen; Christine Joss; Christian von Briel; Ralph A Schmid; Miklos Pless; James Habicht; Arnaud D Roth; Anastase Spiliopoulos; Rolf Stahel; Walter Weder; Roger Stupp; Fritz Egli; Markus Furrer; Hanspeter Honegger; Martin Wernli; Thomas Cerny; Hans-Beat Ris
Journal:  J Clin Oncol       Date:  2003-05-01       Impact factor: 44.544

8.  Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).

Authors:  Wilfried Ernst Erich Eberhardt; Christoph Pöttgen; Thomas Christoph Gauler; Godehard Friedel; Stefanie Veit; Vanessa Heinrich; Stefan Welter; Wilfried Budach; Werner Spengler; Martin Kimmich; Berthold Fischer; Heinz Schmidberger; Dirk De Ruysscher; Claus Belka; Sebastian Cordes; Rodrigo Hepp; Diana Lütke-Brintrup; Nils Lehmann; Martin Schuler; Karl-Heinz Jöckel; Georgios Stamatis; Martin Stuschke
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

9.  Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes.

Authors:  Charlotte Billiet; Dirk De Ruysscher; Stéphanie Peeters; Herbert Decaluwé; Johan Vansteenkiste; Christophe Dooms; Christophe M Deroose; Paul De Leyn; Marc Hendrikx; Paul Bulens; Cécile Le Péchoux; Jeroen Mebis
Journal:  J Thorac Oncol       Date:  2016-06-30       Impact factor: 15.609
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.